Zura Bio (ZURA) Research & Development (2022 - 2026)
Zura Bio's (ZURA) quarterly Research & Development came in at $14.7 million in Q1 2026, up 40.79% year-on-year from $10.5 million in Q1 2025, and up 34.59% quarter-over-quarter from $11.0 million in Q4 2025.
Zura Bio (ZURA) Research & Development (2022 - 2026) Analysis & Trends
Zura Bio's Research & Development history runs 5 years deep, the most recent figure standing at $14.7 million for Q1 2026.
- On a quarterly basis, Research & Development rose 40.79% year-over-year to $14.7 million in Q1 2026; TTM through Mar 2026 was $46.4 million, a 48.18% increase from a year earlier, with the FY2025 full-year figure at $42.1 million, up 72.46% from the prior year.
- Research & Development advanced to $14.7 million in Q1 2026 per ZURA's latest filing, from $11.0 million in the prior quarter.
- Across five years, Research & Development topped out at $28.2 million in Q2 2023 and bottomed at $85000.0 in Q2 2022.
- The 5-year median for Research & Development is $7.5 million (2022), against an average of $8.8 million.
- Across the five-year window, Research & Development surged 33111.76% in 2023 and slumped 80.38% in 2024, its largest moves.
- Year by year, Research & Development stood at $15.7 million in 2022, then sank by 55.89% to $6.9 million in 2023, then surged by 33.53% to $9.2 million in 2024, then advanced by 18.57% to $11.0 million in 2025, then jumped by 34.59% to $14.7 million in 2026.
- Per Business Quant, the three latest ZURA Research & Development figures stand at $14.7 million (Q1 2026), $11.0 million (Q4 2025), and $11.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Zura Bio | 593.66 Mn | 593.66 Mn | - | 14.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.75 Mn |
| Dec 31, 2025 | 10.96 Mn |
| Sep 30, 2025 | 11.95 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 10.47 Mn |
| Dec 31, 2024 | 9.24 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Jun 30, 2024 | 5.54 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 6.92 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Jun 30, 2023 | 28.23 Mn |
| Mar 31, 2023 | 4.88 Mn |
| Dec 31, 2022 | 15.69 Mn |
| Sep 30, 2022 | 415,000.00 |
| Jun 30, 2022 | 85,000.00 |
| Mar 31, 2022 | 7.50 Mn |